Skip to content

Evaluation of the Trabecular Metal™ Revision Hip Cup Using Bone Mineral Density (DEXA)

Evaluation of the Trabecular Metal™ Acetabular Revision Cup Using Dual-Energy X-ray Absorptiometry (DEXA)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01183260
Enrollment
25
Registered
2010-08-17
Start date
2010-08-31
Completion date
2017-01-31
Last updated
2017-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Revision, Joint

Keywords

revision total hip arthroplasty, bone mineral density, trabecular metal, DEXA

Brief summary

In 1997, the FDA approved the use of Trabecular Metal™ (Zimmer, Trabecular Metal Technology, Inc., Parsippany, NJ) for acetabular cups, a porous tantalum structural biomaterial that was developed to address the limitations of other implant materials, with the potential to improve implant fixation. Porous tantalum (80% porosity) offers potentially greater ingrowth and bone graft incorporation, believed to be restricted by the low porosity of other commonly used implants (30%). Additionally, the low modulus of elasticity property (3 MPa) of porous tantalum provides more normal physiological loading conditions which theoretically reduce stress shielding and resultant bone loss surrounding the implant. These properties are much desired advantages for implants used in cementless THA. Various porous tantalum implants have shown favorable clinical results. Unger et al. reported excellent bone graft incorporation of the acetabular component based on serial radiograph data at a minimum 1-year follow-up. Dual-energy X-ray absorptiometry (DEXA) is a well-established method for detecting periprosthetic bone mass changes around the femoral and acetabular THA components. The primary objective of this study is to quantify and compare periprosthetic bone mineral density (BMD) changes in THA revision patients receiving Trabecular Metal™ and metal-backed acetabular components, measured using DEXA scanning techniques. Additionally, this study will analyze and compare clinical outcomes of these patients, based on SF-12v2 and HOOS.

Detailed description

none provided.

Interventions

DEVICETrabecular Metal Revision Cup

Revision of the acetabular cup

DEVICETrabecular Metal Modular Cup

Revision of the acetabular cup

Sponsors

Zimmer Biomet
CollaboratorINDUSTRY
The Cleveland Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Age: 18 - 85 years * Sex: Both male and female will be included. The male-to-female ratio will depend upon the patient population. * Stable Health: At the time of surgery based on physical examination and medical history. * Patient is a revision total hip recipient, which requires a metal-backed hemispherical cup. * Patient or patient's legal representative has signed the Informed Consent form. The patient is capable of making informed decisions regarding his/her healthcare.

Exclusion criteria

* Patients undergoing bilateral surgery or had prior hip arthroplasty on contralateral side less than 6 months from date of surgery. * Patients who do not plan to return to a Cleveland Clinic surgeon for follow-up visits (i.e. out of state/country patients who may choose to follow-up with a different surgeon). * Patients with history of radiation therapy. * Patients with known diagnosis of Brooker grade 3 or 4 HO (heterotopic ossification) in the hip joint region. * Patients with known diagnosis of renal disease. * Patients with known diagnosis of osteoporosis. * Patients with history of steroid use in the hip joint region. * Patients that have had a previous lumbar fusion. * Patients whose surgical reconstruction required a pelvic cage or plate. * Patient was a poor compliance risk - treated for ethanol or drug abuse, physical or mental handicap, etc. * Any female of childbearing potential who is pregnant or is planning on becoming pregnant during the study period (\ 2 years postoperative).

Design outcomes

Primary

MeasureTime frameDescription
Periprosthetic Bone Mineral Density (BMD) of Hip2 years postoperative; measured at 3 months (baseline), 6 months, 1 year, 2 year postoperativeQuantify and compare periprosthetic bone mineral density (BMD) changes in THA revision patients receiving Trabecular Metal™ and metal-backed acetabular components, measured using DEXA scanning techniques. Region 1 forms the superior-lateral region, Region 2 forms the superior-medial region, and Region 3 forms the inferior-medial region around the acetabular component. For each region, the mean change in BMD was calculated using the following equation described by Wilkinson et al (J Bone Joint Surg Br., 2001): mean percent change in BMD = (BMD1-BMD2) x 2 x 100 / (BMD1 + BMD2). These regions were patient specific and remained the same each time the patient was scanned.

Secondary

MeasureTime frameDescription
Functional and General Health Outcome Assessments2 years postoperative; measured preoperatively and 3 months, 6 months, 1 year, 2 year postoperativeAnalyze and compare functional and general health outcomes of these patients, based on Hip disability and Osteoarthritis Outcomes Score (HOOS) and 12-item Short Form Health Survey (SF-12v2). All subscale scores are calculated independently and range from 0 to 100, where 100 indicates no problems: * SF-12 Physical Component Summary Subscale (SF12 PCS) assesses physical function, bodily pain, and general health. * SF-12 Mental Component Summary Subscale (SF12 MCS) assesses emotional and mental health. * HOOS Pain assesses pain in the hip * HOOS Symptoms assesses symptoms such as stiffness in the hip * HOOS activities of daily living (HOOS ADL) assesses physical function while performing common daily activities (walking, sitting, standing, etc.) * HOOS sport and recreation (HOOS Sports/Rec) assesses physical function while performing higher-level activities (running, squatting, etc.) * HOOS hip-related quality of life (HOOS QOL) assesses how much the hip impacts life

Countries

United States

Participant flow

Recruitment details

Recruitment period: 2010 - 2014

Participants by arm

ArmCount
Zimmer Trabecular Metal Acetabular Cup
Zimmer Trabecular Metal Revision Cup: Revision of the acetabular cup
10
Zimmer Modular Cup
Zimmer Modular Cup: Revision of the acetabular cup
9
Total19

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDeath10
Overall StudyIntraop screen failure20
Overall StudyRevised within 30 days01
Overall StudyWithdrawal by Subject11

Baseline characteristics

CharacteristicZimmer Trabecular Metal Acetabular CupZimmer Modular CupTotal
Age, Continuous58.60 years
STANDARD_DEVIATION 11.4
61.11 years
STANDARD_DEVIATION 9.74
59.79 years
STANDARD_DEVIATION 10.15
BMI (kg/m^2), Continuous30.14 kg/m^2
STANDARD_DEVIATION 6.07
30.49 kg/m^2
STANDARD_DEVIATION 7.56
30.31 kg/m^2
STANDARD_DEVIATION 6.44
Operative Side: Left, Right
Left
5 Participants5 Participants10 Participants
Operative Side: Left, Right
Right
5 Participants4 Participants9 Participants
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
10 Participants9 Participants19 Participants
Sex: Female, Male
Female
4 Participants5 Participants9 Participants
Sex: Female, Male
Male
6 Participants4 Participants10 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
1 / 140 / 11
other
Total, other adverse events
0 / 140 / 11
serious
Total, serious adverse events
0 / 141 / 11

Outcome results

Primary

Periprosthetic Bone Mineral Density (BMD) of Hip

Quantify and compare periprosthetic bone mineral density (BMD) changes in THA revision patients receiving Trabecular Metal™ and metal-backed acetabular components, measured using DEXA scanning techniques. Region 1 forms the superior-lateral region, Region 2 forms the superior-medial region, and Region 3 forms the inferior-medial region around the acetabular component. For each region, the mean change in BMD was calculated using the following equation described by Wilkinson et al (J Bone Joint Surg Br., 2001): mean percent change in BMD = (BMD1-BMD2) x 2 x 100 / (BMD1 + BMD2). These regions were patient specific and remained the same each time the patient was scanned.

Time frame: 2 years postoperative; measured at 3 months (baseline), 6 months, 1 year, 2 year postoperative

Population: By Year 2, there were 3 patients lost to follow-up in the Revision Cup group and 3 patients lost to follow-up in the Modular Cup group:~We were unable to contact 1 patient from each group in order to schedule follow-up The remaining patients were withdrawn because they were feeling fine and declined to return for follow-up at that time

ArmMeasureGroupValue (MEAN)Dispersion
Zimmer Trabecular Metal Acetabular CupPeriprosthetic Bone Mineral Density (BMD) of Hip3 Month - Region 11.63 g/cm^2Standard Deviation 0.42
Zimmer Trabecular Metal Acetabular CupPeriprosthetic Bone Mineral Density (BMD) of Hip3 Month - Region 21.85 g/cm^2Standard Deviation 0.34
Zimmer Trabecular Metal Acetabular CupPeriprosthetic Bone Mineral Density (BMD) of Hip3 Month - Region 31.27 g/cm^2Standard Deviation 0.33
Zimmer Trabecular Metal Acetabular CupPeriprosthetic Bone Mineral Density (BMD) of Hip3 Month - Lumbar Spine (L1-L4)1.29 g/cm^2Standard Deviation 0.15
Zimmer Trabecular Metal Acetabular CupPeriprosthetic Bone Mineral Density (BMD) of Hip6 Month - Region 11.61 g/cm^2Standard Deviation 0.18
Zimmer Trabecular Metal Acetabular CupPeriprosthetic Bone Mineral Density (BMD) of Hip6 Month - Region 21.75 g/cm^2Standard Deviation 0.31
Zimmer Trabecular Metal Acetabular CupPeriprosthetic Bone Mineral Density (BMD) of Hip6 Month - Region 31.22 g/cm^2Standard Deviation 0.3
Zimmer Trabecular Metal Acetabular CupPeriprosthetic Bone Mineral Density (BMD) of Hip6 Month - Lumbar Spine (L1-L4)1.29 g/cm^2Standard Deviation 0.17
Zimmer Trabecular Metal Acetabular CupPeriprosthetic Bone Mineral Density (BMD) of Hip1 Year - Region 11.64 g/cm^2Standard Deviation 0.17
Zimmer Trabecular Metal Acetabular CupPeriprosthetic Bone Mineral Density (BMD) of Hip1 Year - Region 21.82 g/cm^2Standard Deviation 0.28
Zimmer Trabecular Metal Acetabular CupPeriprosthetic Bone Mineral Density (BMD) of Hip1 Year - Region 31.23 g/cm^2Standard Deviation 0.14
Zimmer Trabecular Metal Acetabular CupPeriprosthetic Bone Mineral Density (BMD) of Hip1 Year - Lumbar Spine (L1-L4)1.26 g/cm^2Standard Deviation 0.14
Zimmer Trabecular Metal Acetabular CupPeriprosthetic Bone Mineral Density (BMD) of Hip2 Year - Region 11.75 g/cm^2Standard Deviation 0.23
Zimmer Trabecular Metal Acetabular CupPeriprosthetic Bone Mineral Density (BMD) of Hip2 Year - Region 21.76 g/cm^2Standard Deviation 0.24
Zimmer Trabecular Metal Acetabular CupPeriprosthetic Bone Mineral Density (BMD) of Hip2 Year - Region 31.19 g/cm^2Standard Deviation 0.24
Zimmer Trabecular Metal Acetabular CupPeriprosthetic Bone Mineral Density (BMD) of Hip2 Year - Lumbar Spine (L1-L4)1.26 g/cm^2Standard Deviation 0.14
Zimmer Modular CupPeriprosthetic Bone Mineral Density (BMD) of Hip2 Year - Lumbar Spine (L1-L4)1.15 g/cm^2Standard Deviation 0.14
Zimmer Modular CupPeriprosthetic Bone Mineral Density (BMD) of Hip3 Month - Region 11.64 g/cm^2Standard Deviation 0.38
Zimmer Modular CupPeriprosthetic Bone Mineral Density (BMD) of Hip1 Year - Region 11.84 g/cm^2Standard Deviation 0.34
Zimmer Modular CupPeriprosthetic Bone Mineral Density (BMD) of Hip3 Month - Region 21.64 g/cm^2Standard Deviation 0.31
Zimmer Modular CupPeriprosthetic Bone Mineral Density (BMD) of Hip2 Year - Region 11.93 g/cm^2Standard Deviation 0.45
Zimmer Modular CupPeriprosthetic Bone Mineral Density (BMD) of Hip3 Month - Region 30.92 g/cm^2Standard Deviation 0.31
Zimmer Modular CupPeriprosthetic Bone Mineral Density (BMD) of Hip1 Year - Region 21.72 g/cm^2Standard Deviation 0.41
Zimmer Modular CupPeriprosthetic Bone Mineral Density (BMD) of Hip3 Month - Lumbar Spine (L1-L4)1.21 g/cm^2Standard Deviation 0.18
Zimmer Modular CupPeriprosthetic Bone Mineral Density (BMD) of Hip2 Year - Region 31.00 g/cm^2Standard Deviation 0.36
Zimmer Modular CupPeriprosthetic Bone Mineral Density (BMD) of Hip6 Month - Region 11.82 g/cm^2Standard Deviation 0.28
Zimmer Modular CupPeriprosthetic Bone Mineral Density (BMD) of Hip1 Year - Region 31.22 g/cm^2Standard Deviation 0.16
Zimmer Modular CupPeriprosthetic Bone Mineral Density (BMD) of Hip6 Month - Region 21.76 g/cm^2Standard Deviation 0.33
Zimmer Modular CupPeriprosthetic Bone Mineral Density (BMD) of Hip2 Year - Region 21.83 g/cm^2Standard Deviation 0.71
Zimmer Modular CupPeriprosthetic Bone Mineral Density (BMD) of Hip6 Month - Region 30.94 g/cm^2Standard Deviation 0.3
Zimmer Modular CupPeriprosthetic Bone Mineral Density (BMD) of Hip1 Year - Lumbar Spine (L1-L4)1.22 g/cm^2Standard Deviation 0.16
Zimmer Modular CupPeriprosthetic Bone Mineral Density (BMD) of Hip6 Month - Lumbar Spine (L1-L4)1.22 g/cm^2Standard Deviation 0.16
Secondary

Functional and General Health Outcome Assessments

Analyze and compare functional and general health outcomes of these patients, based on Hip disability and Osteoarthritis Outcomes Score (HOOS) and 12-item Short Form Health Survey (SF-12v2). All subscale scores are calculated independently and range from 0 to 100, where 100 indicates no problems: * SF-12 Physical Component Summary Subscale (SF12 PCS) assesses physical function, bodily pain, and general health. * SF-12 Mental Component Summary Subscale (SF12 MCS) assesses emotional and mental health. * HOOS Pain assesses pain in the hip * HOOS Symptoms assesses symptoms such as stiffness in the hip * HOOS activities of daily living (HOOS ADL) assesses physical function while performing common daily activities (walking, sitting, standing, etc.) * HOOS sport and recreation (HOOS Sports/Rec) assesses physical function while performing higher-level activities (running, squatting, etc.) * HOOS hip-related quality of life (HOOS QOL) assesses how much the hip impacts life

Time frame: 2 years postoperative; measured preoperatively and 3 months, 6 months, 1 year, 2 year postoperative

Population: By Year 2, there were 3 patients lost to follow-up in the Revision Cup group and 3 patients lost to follow-up in the Modular Cup group:~We were unable to contact 1 patient from each group in order to schedule follow-up

ArmMeasureGroupValue (MEAN)Dispersion
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome Assessments2 Year SF12 MCS53.46 units on a scaleStandard Deviation 7.93
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome Assessments3 Month HOOS Sports/Rec21.88 units on a scaleStandard Deviation 16.39
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome Assessments6 Month SF12 MCS50.51 units on a scaleStandard Deviation 11.53
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome Assessments3 Month HOOS QOL28.89 units on a scaleStandard Deviation 16.73
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome AssessmentsPreop HOOS Pain50.25 units on a scaleStandard Deviation 20.19
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome Assessments6 Month HOOS Pain61.94 units on a scaleStandard Deviation 19.07
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome Assessments3 Month SF12 MCS51.78 units on a scaleStandard Deviation 8.1
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome Assessments6 Month HOOS Symptoms58.33 units on a scaleStandard Deviation 17.68
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome AssessmentsPreop HOOS Symptoms46.50 units on a scaleStandard Deviation 18.72
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome Assessments6 Month HOOS ADL55.56 units on a scaleStandard Deviation 15.71
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome Assessments1 Year SF12 PCS31.04 units on a scaleStandard Deviation 12.54
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome Assessments6 Month HOOS Sports/Rec26.39 units on a scaleStandard Deviation 18
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome AssessmentsPreop HOOS ADL39.48 units on a scaleStandard Deviation 8.63
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome Assessments6 Month HOOS QOL37.04 units on a scaleStandard Deviation 23.57
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome Assessments3 Month SF12 PCS32.25 units on a scaleStandard Deviation 8.38
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome Assessments1 Year HOOS Pain61.88 units on a scaleStandard Deviation 27.57
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome AssessmentsPreop HOOS Sports/Rec8.75 units on a scaleStandard Deviation 12.96
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome Assessments1 Year HOOS Symptoms63.75 units on a scaleStandard Deviation 30.68
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome Assessments1 Year SF12 MCS55.58 units on a scaleStandard Deviation 10.18
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome Assessments1 Year HOOS ADL56.88 units on a scaleStandard Deviation 26.8
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome AssessmentsPreop HOOS QOL28.89 units on a scaleStandard Deviation 31.95
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome Assessments1 Year HOOS Sports/Rec20.49 units on a scaleStandard Deviation 20.68
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome Assessments6 Month SF12 PCS32.14 units on a scaleStandard Deviation 7.22
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome Assessments1 Year HOOS QOL38.89 units on a scaleStandard Deviation 31.98
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome Assessments3 Month HOOS Pain61.50 units on a scaleStandard Deviation 16.72
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome Assessments2 Year HOOS Pain69.64 units on a scaleStandard Deviation 26.71
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome Assessments2 Year SF12 PCS36.10 units on a scaleStandard Deviation 11.39
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome Assessments2 Year HOOS Symptoms65.54 units on a scaleStandard Deviation 23.98
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome Assessments3 Month HOOS Symptoms55.50 units on a scaleStandard Deviation 19.5
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome Assessments2 Year HOOS ADL66.19 units on a scaleStandard Deviation 26.93
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome AssessmentsPreop SF12 MCS55.29 units on a scaleStandard Deviation 8.07
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome Assessments2 Year HOOS Sports/Rec39.58 units on a scaleStandard Deviation 25.43
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome Assessments3 Month HOOS ADL52.45 units on a scaleStandard Deviation 14.23
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome Assessments2 Year HOOS QOL60.32 units on a scaleStandard Deviation 29.99
Zimmer Trabecular Metal Acetabular CupFunctional and General Health Outcome AssessmentsPreop SF12 PCS32.25 units on a scaleStandard Deviation 5.86
Zimmer Modular CupFunctional and General Health Outcome Assessments2 Year HOOS QOL62.96 units on a scaleStandard Deviation 24
Zimmer Modular CupFunctional and General Health Outcome AssessmentsPreop SF12 PCS38.57 units on a scaleStandard Deviation 12.07
Zimmer Modular CupFunctional and General Health Outcome AssessmentsPreop SF12 MCS47.62 units on a scaleStandard Deviation 10.39
Zimmer Modular CupFunctional and General Health Outcome Assessments3 Month SF12 PCS38.57 units on a scaleStandard Deviation 11.63
Zimmer Modular CupFunctional and General Health Outcome Assessments3 Month SF12 MCS51.09 units on a scaleStandard Deviation 9.45
Zimmer Modular CupFunctional and General Health Outcome Assessments6 Month SF12 PCS40.12 units on a scaleStandard Deviation 13
Zimmer Modular CupFunctional and General Health Outcome Assessments6 Month SF12 MCS52.83 units on a scaleStandard Deviation 7.7
Zimmer Modular CupFunctional and General Health Outcome Assessments1 Year SF12 PCS42.84 units on a scaleStandard Deviation 16.14
Zimmer Modular CupFunctional and General Health Outcome Assessments1 Year SF12 MCS54.04 units on a scaleStandard Deviation 8.64
Zimmer Modular CupFunctional and General Health Outcome Assessments2 Year SF12 PCS47.05 units on a scaleStandard Deviation 13.52
Zimmer Modular CupFunctional and General Health Outcome Assessments2 Year SF12 MCS48.66 units on a scaleStandard Deviation 11.24
Zimmer Modular CupFunctional and General Health Outcome AssessmentsPreop HOOS Pain36.67 units on a scaleStandard Deviation 25.19
Zimmer Modular CupFunctional and General Health Outcome AssessmentsPreop HOOS Symptoms38.33 units on a scaleStandard Deviation 27.95
Zimmer Modular CupFunctional and General Health Outcome AssessmentsPreop HOOS ADL32.11 units on a scaleStandard Deviation 31.24
Zimmer Modular CupFunctional and General Health Outcome AssessmentsPreop HOOS Sports/Rec15.28 units on a scaleStandard Deviation 21.4
Zimmer Modular CupFunctional and General Health Outcome AssessmentsPreop HOOS QOL27.16 units on a scaleStandard Deviation 25.53
Zimmer Modular CupFunctional and General Health Outcome Assessments3 Month HOOS Pain76.39 units on a scaleStandard Deviation 17.37
Zimmer Modular CupFunctional and General Health Outcome Assessments3 Month HOOS Symptoms66.67 units on a scaleStandard Deviation 18.03
Zimmer Modular CupFunctional and General Health Outcome Assessments3 Month HOOS ADL66.81 units on a scaleStandard Deviation 17.09
Zimmer Modular CupFunctional and General Health Outcome Assessments3 Month HOOS Sports/Rec29.17 units on a scaleStandard Deviation 15.8
Zimmer Modular CupFunctional and General Health Outcome Assessments3 Month HOOS QOL49.38 units on a scaleStandard Deviation 30.99
Zimmer Modular CupFunctional and General Health Outcome Assessments6 Month HOOS Pain81.94 units on a scaleStandard Deviation 14.02
Zimmer Modular CupFunctional and General Health Outcome Assessments6 Month HOOS Symptoms76.67 units on a scaleStandard Deviation 19.04
Zimmer Modular CupFunctional and General Health Outcome Assessments6 Month HOOS ADL76.79 units on a scaleStandard Deviation 17.15
Zimmer Modular CupFunctional and General Health Outcome Assessments6 Month HOOS Sports/Rec46.13 units on a scaleStandard Deviation 29.98
Zimmer Modular CupFunctional and General Health Outcome Assessments6 Month HOOS QOL49.38 units on a scaleStandard Deviation 37.31
Zimmer Modular CupFunctional and General Health Outcome Assessments1 Year HOOS Pain81.67 units on a scaleStandard Deviation 12.18
Zimmer Modular CupFunctional and General Health Outcome Assessments1 Year HOOS Symptoms75.83 units on a scaleStandard Deviation 18.03
Zimmer Modular CupFunctional and General Health Outcome Assessments1 Year HOOS ADL76.88 units on a scaleStandard Deviation 17.77
Zimmer Modular CupFunctional and General Health Outcome Assessments1 Year HOOS Sports/Rec51.49 units on a scaleStandard Deviation 19.79
Zimmer Modular CupFunctional and General Health Outcome Assessments1 Year HOOS QOL56.79 units on a scaleStandard Deviation 37.45
Zimmer Modular CupFunctional and General Health Outcome Assessments2 Year HOOS Pain82.92 units on a scaleStandard Deviation 24.41
Zimmer Modular CupFunctional and General Health Outcome Assessments2 Year HOOS Symptoms70.00 units on a scaleStandard Deviation 29.83
Zimmer Modular CupFunctional and General Health Outcome Assessments2 Year HOOS ADL77.38 units on a scaleStandard Deviation 18.65
Zimmer Modular CupFunctional and General Health Outcome Assessments2 Year HOOS Sports/Rec65.83 units on a scaleStandard Deviation 20.92

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026